SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-107034
Filing Date
2024-10-08
Accepted
2024-10-08 16:05:27
Documents
4
Period of Report
2024-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2425747d1_6k.htm 6-K 18888
2 EXHIBIT 99.1 tm2425747d1_ex99-1.htm EX-99.1 43824
3 EXHIBIT 99.2 tm2425747d1_ex99-2.htm EX-99.2 42362
4 EXHIBIT 99.3 tm2425747d1_ex99-3.htm EX-99.3 24557
  Complete submission text file 0001104659-24-107034.txt   130730
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41937 | Film No.: 241360373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)